<DOC>
	<DOCNO>NCT00553891</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled study document long-term effect treatment mometasone furoate nasal spray moderate severe adenoid hypertrophy reflect need removal adenoid within one year treatment regimen . Subjects assign treat either mometasone furoate nasal spray placebo 3 month . Subjects follow addition 12 month . Serious AEs follow start first dose-till 30 day study treatment period completion . This study terminate - Please see `` P04367 - Lebanon ''</brief_summary>
	<brief_title>Placebo-controlled Trial With Nasonex Nasal Obstruction Secondary Adenoids Hypertrophy Children ( P04367 ) ( TERMINATED )</brief_title>
	<detailed_description />
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Nasal Obstruction</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Should 2 11 year . Should nasal obstruction least 3 month . Should evidence adenoid hypertrophy nasopharyngoscopy , cause &gt; 50 % obstruction posterior choanae . May concomitant allergic rhinitis , history , &amp; specific blood study ; however , symptom control study period . Patients less 50 % obstruction post choanae . Patients history recurrent epistaxis immunodeficiency . Patients severe septal deviation . Patients unilateral bilateral choanal atresia , large nasal polyp nasal mass . Known allergy drug . Presence chronic otitis medium define : otorreha + perforation ( concomitant otitis medium effusion , recurrent otitis medium exclude ) . Cystic fibrosis &amp; cause responsible nasal obstruction . Infection ( ie ; sinusitis ) . History recent surgery trauma nose , unless wound heal .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>